Deisseroth, Hegemann and Nagel share the medicine Nobel for optogenetics

Karl Deisseroth, Peter Hegemann and Georg Nagel won the 2026 Nobel Prize in Physiology or Medicine on Monday for discoveries on light-gated ion channels and for optogenetics. The Nobel Assembly at Karolinska Institutet said the work makes it possible to switch the activity of individual nerve cells on or off in a living brain. The prize is 12 million Swedish kronor, shared by the three.

The tool starts in algae, not in a clinic. Some microbes carry channelrhodopsins, proteins that open a pore when blue light hits them and let charged ions cross the membrane. Hegemann and Nagel identified and characterised those proteins and showed they could be moved into other cells and still work. A neuron that makes the protein will fire, or go quiet, when a fibre delivers the matching light. Deisseroth took that reagent into neuroscience. He put the gene into chosen neurons in living animals, wired light to those cells, and used the switch to test which circuits produce a movement, a memory, or a state. The method is now a standard in laboratories that map behaviour to cells.

The older tools could not do this cleanly. An electrode stimulates everything near the tip. A drug washes through a region. Optogenetics asks for a genetic address and a colour of light. A researcher can label one cell type, leave the neighbours dark, and ask what that type does. The Assembly's line is that the method is being used around the world to study how the brain makes memory, feeling and behaviour. That is a laboratory claim, not a treatment claim. Clinical trials that use light and these proteins in people are a separate, slower track. Monday's citation does not say a disease has been cured.

The three names split the work in a way a reader can check. Hegemann, a biophysicist, spent years on the photochemistry of algal eyespots. Nagel, working with him, showed that the channel could be expressed in other cells and opened by light. Deisseroth, a psychiatrist and bioengineer at Stanford, published the mammalian demonstrations that made the method a system: gene, fibre, behaviour, in the same animal. Later variants changed the colour, the ion, and the speed, so a lab can now excite one population and silence another in the same session. Those variants sit on the original channel.

The prize is the first of this Nobel week. Physics followed on Tuesday for Francis Halzen and IceCube. Chemistry followed on Wednesday for Henri Kagan and Kenso Soai. Literature followed on Thursday for Anne Carson. Medicine's place on Monday is a reminder that the week is a sequence of committees, not one jury. The Karolinska assembly does not consult the Swedish Academy of Sciences before it votes.

For a working neuroscientist the information in the citation is the permission structure of the method. Light-gated means the experimenter, not the cell's own chemistry, chooses the moment. Ion channel means the effect is electrical and fast, on the order of the spike itself. Individual nerve cells means the address can be a type, or in some setups a single cell, rather than a whole nucleus. Anyone buying a kit this year is buying a descendant of the algal protein these three made usable. The open clinical question, which the citation does not answer, is whether a protein that works in a mouse cortex can be delivered, targeted and lit safely in a human patient. That work is under way in several labs. It is not what Monday's prize declared finished.